• OPEN AN ACCOUNT
Indian Indices
Nifty
25,003.05 252.15
(1.02%)
Sensex
82,188.99 746.95
( 0.92%)
Bank Nifty
56,578.40 817.55
( 1.47%)
Nifty IT
37,294.85 186.90
( 0.50%)
Global Indices
Nasdaq
42,779.54 438.80
(1.04%)
Dow Jones
6,020.48 60.18
(1.01%)
Hang Seng
37,687.53 133.04
(0.35%)
Nikkei 225
8,837.91 26.87
(0.30%)
Forex
USD-INR
85.85 0.27
(0.32%)
EUR-INR
97.86 0.31
(0.32%)
GBP-INR
116.24 0.53
(0.46%)
JPY-INR
0.60 0.00
(0.24%)

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78690
INE0MRE01011
67.838225
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INFINIUM
52.49
444.12
EPS(TTM)
Face Value()
Div & Yield %
5.43
10
0
 

atul ltd
Markobenz Ventures standalone net profit declines 86.40% in the March 2025 quarter
May 31,2025
Net profit of Markobenz Ventures declined 86.40% to Rs 0.17 crore in the quarter ended March 2025 as against Rs 1.25 crore during the previous quarter ended March 2024. Sales rose 48.80% to Rs 18.57 crore in the quarter ended March 2025 as against Rs 12.48 crore during the previous quarter ended March 2024.

For the full year,net profit declined 17.81% to Rs 1.80 crore in the year ended March 2025 as against Rs 2.19 crore during the previous year ended March 2024. Sales rose 168.68% to Rs 64.08 crore in the year ended March 2025 as against Rs 23.85 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales18.5712.48 49 64.0823.85 169
OPM %5.1710.02 -4.047.30 -
PBDT0.901.25 -28 2.532.19 16
PBT0.901.25 -28 2.532.19 16
NP0.171.25 -86 1.802.19 -18